abstract |
The present invention relates to the use of a composition comprising of at least a mutated antithrombin - having an anticoagulant activity substantially reduced with respect to the anticoagulant activity of the non mutated antithrombin, or - having no anticoagulant activity, for the preparation of a drug intended for the prevention or the treatment of pathologies associated with cellular injury, such as infection, inflammation or hypoxic injury. |